Minshan Chen

11.2k citations
211 papers · 8k · 5 hit papers · h-index 42

Impact in

  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Inflammatory Biomarkers in Disease Prognosis

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 155
    • Inflammatory Biomarkers in Disease Prognosis 11
    • Cancer Immunotherapy and Biomarkers 8
    • Cancer Cells and Metastasis 2

Minshan Chen

200 papers receiving 7.9k citations

Minshan Chen's Hit Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial 2023 · 374 citations
3740+3+7Years since publication2505007501k

Peers

Minshan Chen
Comparison fields: 5 of 113
  • Hepatology 5k
  • Oncology 915
  • Cancer Research 422
  • Epidemiology 554
  • Radiology, Nuclear Medicine and Imaging 361
Replace Su Jong Yu with:
Su Jong Yu South Korea
Alessandro Granito Italy
Matthias Pinter Austria
Sadahisa Ogasawara Japan
Angelo Sangiovanni Italy
Tan To Cheung Hong Kong
James Oh Park United States
Enrico Narciso De Toni Germany
Joachim C. Mertens Switzerland
Wen‐Ming Cong China
Minshan Chen relative to Su Jong Yu South Korea Su Jong Yu's profile →
Citations per field
00.5×1.5×1.9×
Su Jong Yu · 1×
Citations per year

Countries citing papers authored by Minshan Chen

Since Specialization
Citations

This map shows the geographic impact of Minshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minshan Chen more than expected).

Fields of papers citing papers by Minshan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minshan Chen. The network helps show where Minshan Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Minshan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minshan Chen Line = papers co-authored together Minshan Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Hit paper breakdown →
20151023
2
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Hit paper breakdown →
2020619
3
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2023374
4
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Hit paper breakdown →
2023309
5 2010298
6 2015218
7 2020175
8 2012173
9 2021164
10 2018148
11
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Hit paper breakdown →
2022148
12 2018136
13 2019125
14 2011112
15 2018111
16 2018110
17 2013107
18 201893
19 202390
20 201379

About Minshan Chen

Minshan Chen is a scholar working on Hepatology, Oncology, Epidemiology, Cancer Research and Surgery, having authored 211 papers that have together received 8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (155 papers), Hepatitis B Virus Studies (14 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (3 papers), Minimally Invasive Surgical Techniques (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Hepatology (5k citations), Oncology (915 citations), Cancer Research (422 citations), Epidemiology (554 citations) and Radiology, Nuclear Medicine and Imaging (361 citations). Minshan Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yaojun Zhang, Li Xu, Masatoshi Kudo, Rong Guo, Lucinda Strycker Orsini, Zhongguo Zhou, Joong‐Won Park, Myron Schwartz, Samuel Wagner and Morris Sherman. Their work appears in journals such as Liver Cancer, International Journal of Surgery, Hepatology, Hepatology International and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact